Duran, SadıkBulur, SerkanSözen, Serhat BahadırBilir, CemilUyan, CihangirAkdemir, Ramazan2021-06-232021-06-2320061472-02051472-0213https://doi.org/10.1136/emj.2005.030965https://hdl.handle.net/20.500.12491/5956Cardiotoxicity is an uncommon adverse effect of 5-FU treatment. Prevalence of 5- fluorouracil (FU) - induced cardiotoxicity is 2–18%, and represents an interesting clinical challenge.1 A 62 year old male was admitted to our emergency department with severe dyspnea, chest pain, diaphoresis, nausea, and pruritis after the completition of a regimen of 5-FU chemotherapy for gastric adenocarcinoma.eninfo:eu-repo/semantics/openAccessAcute DiseaseEmergency MedicineCoronary VasospasmFluorouracilChemotherapyEditorial10.1136/emj.2005.0309652318585163738182-s2.0-33646093746Q1WOS:000234147700027Q3